President Donald Trump, during a press conference in the White House Rose Garden earlier this week, stressed that he refuses to work with Democrats in Congress on infrastructure projects as long as they continue to investigate him. But infrastructure isn’t the only thing Trump is holding hostage: on Friday, the president declared that he can’t work with Democrats on prescription drug prices either unless all investigations cease.
Trump asserted that “with Congress,” he could reduce drug prices in the U.S. by “40 percent and 50 percent, but I can’t do that when all they do is want to try and do a redo of the Mueller report.”
Bloomberg News’ Steven Dennis addressed Trump’s threat on Twitter, commenting, “So, if you’re Pharma, do you now hope for a year of impeachment proceedings?” And one Republican who, according to Dennis, clearly wants to see Trump and Democrats in Congress working together on reducing prescription drug prices is Maine Sen. Susan Collins—who told Bloomberg she thinks Trump will reconsider because he “wants action” on drug prices and other issues.
Sen. Lindsey Graham, ordinarily a passionate supporter of Trump, is also worried about Trump’s threat to quit working with House and Senate Democrats on key issues—telling Bloomberg that while he understands Trump’s “frustration,” refusing to work with Democrats in Congress altogether is “not a sustainable position.” The South Carolina Republican warned that the party giving the impression that “they don’t want to govern at all is going to be in real trouble.”
According to the Commonwealth Fund, the U.S. has the highest prescription drug prices in the developed world—spending $1011 per capita compared to $351 per capita in Sweden, $401 per capita in Norway, $553 per capita in France or $686 per capita in Germany.